- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02352857
Glycaemic and Insulinaemic Responses After Consumption of FOS. (GLYCOFOS-cake)
January 28, 2015 updated by: Jean-Michel Lecerf, Institut Pasteur de Lille
Postprandial Glycaemic and Insulinaemic Responses After Consumption of Minicakes Containing FOS in Adults
The study aims to evaluate the glycaemic and insulinaemic response of short-chain fructo-oligosaccharides (scFOS) used to replace sugars (e.g.
dextrose) in foods.
Study Overview
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nord
-
Lille, Nord, France, 59019
- NutrInvest - Institut Pasteur de Lille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Body mass index (BMI) between 18.0 and 25.0 kg/m² (included);
- Ready to keep the same volume of physical activity and the same dietary habits during the study and particularly 24 hours before each visit;
- Be used to have breakfast;
- Non-smoker for at least 3 months;
- For the female participant: not being pregnant or breastfeeding and using efficient birth control;
- Signed the consent form;
- Able to follow the instructions of the study;
- Health insured;
- Accepted to be included in the National Registry for biomedical research Volunteers (Fichier VRB, Volontaires Recherches Biomédicales).
Exclusion Criteria:
- Fasting blood glucose over 6.1 mmol/L (1.10 g/L) (or diabetes treated or not);
- Fasting blood cholesterol over 6.35 mmol/L;
- Fasting blood triglycerides over 1.70 mmol/L (or history of insulinoma);
- Fasting blood insulin under 20 mU/L;
- Fasting HbA1c under 7%;
- History of hypercholesterolemia, hypertension, diabetes or glucose intolerance treated or not;
- History of dietary allergies or coeliac disease;
- History of digestive system disease susceptible to modify digestion or absorption like Crohn's disease;
- Somatic or psychiatric disorders;
- Renal insufficiency (kidney failure);
- SGOT or ALAT over 52.5 U/L;
- Smoker;
- Consuming more than 3 alcoholic beverage a day;
- Weight varied 3 kg the last 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Sugar
Control group consuming sponge cakes containing in total 24g of dextrose.
|
100g of sponge cakes made with 24g of dextrose.
|
Experimental: FOS
Group consuming sponge cakes in which 30% of the dextrose was replaced by FOS.
|
100g of sponge cakes made with 19.4g of dextrose and 9.1g of FOS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glycaemic response
Time Frame: 2 hours and 5 minutes
|
Blood glucose kinetics with 7 points.
Analysis of the Area under the curve of glucose.
|
2 hours and 5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulinaemic response
Time Frame: 2 hours and 5 minutes
|
Blood insulin kinetics with 7 points.
Analysis of the Area under the curve of insulin.
|
2 hours and 5 minutes
|
Blood glucose peak (Cmax)
Time Frame: One-time data (the highest one) within the 2hrs 5mins kinetics.
|
Peak of blood glucose during kinetics.
|
One-time data (the highest one) within the 2hrs 5mins kinetics.
|
Blood insulin peak (Cmax)
Time Frame: One-time data (the highest one) within the 2hrs 5mins kinetics.
|
Peak of blood insulin during kinetics.
|
One-time data (the highest one) within the 2hrs 5mins kinetics.
|
Glucose Tmax : time to reach the peak of blood glucose
Time Frame: One time within the 2hrs 5mins kinetics.
|
One time within the 2hrs 5mins kinetics.
|
|
Insulin Tmax : time to reach the peak of blood insulin
Time Frame: One time within the 2hrs 5mins kinetics.
|
One time within the 2hrs 5mins kinetics.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jean-Michel LECERF, MD, Institut Pasteur de Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
November 25, 2013
First Submitted That Met QC Criteria
January 28, 2015
First Posted (Estimate)
February 2, 2015
Study Record Updates
Last Update Posted (Estimate)
February 2, 2015
Last Update Submitted That Met QC Criteria
January 28, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 2013-A00785-40
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycaemia
-
Institut Pasteur de LilleSyralCompleted
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustEnrolling by invitation
-
Northumbria UniversityCompletedAppetite | Postprandial Glycaemia, | Postprandial InsulinaemiaUnited Kingdom
-
Mondelēz International, Inc.University of Sydney; Glycemic Index Laboratories, Inc; BioFortisCompletedGlycaemia | InsulinemiaAustralia, Canada, France
-
St Mary's University CollegeCompletedPost-prandial GlycaemiaUnited Kingdom
-
St. Boniface HospitalUniversity of Manitoba; Agriculture and Agri-Food CanadaActive, not recruiting
Clinical Trials on Sugar
-
Wageningen UniversityCompleted
-
University of BrasiliaConselho Nacional de Desenvolvimento Científico e Tecnológico; MRC Human Nutrition...Completed
-
Purdue UniversityGrain Food FoundationRecruitingHigh Whole Grain and Low Sugar | Medium Whole Grain and Low Sugar | Low Whole Grain and Low Sugar | Low Whole Grain and High SugarUnited States
-
VU University of AmsterdamDutch Heart Foundation; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsCompleted
-
University of DelawareCompletedHealthy Aging | Healthy DietUnited States
-
Region SkaneEnrolling by invitationIrritable Bowel Syndrome | Sucrase-Isomaltase DeficiencySweden
-
University of DelawareNational Institute of General Medical Sciences (NIGMS)Active, not recruitingAging | Healthy DietUnited States
-
Virginia Polytechnic Institute and State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedValidation StudiesUnited States
-
Services Hospital, LahoreCompletedPostoperative IleusPakistan
-
Liverpool School of Tropical MedicineCenters for Disease Control and Prevention; PATH; Kenya Medical Research Institute and other collaboratorsRecruiting